Metagenomi Inc [MGX] stock is trading at $2.69, up 1.51%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MGX shares have gain 16.96% over the last week, with a monthly amount glided 40.84%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Metagenomi Inc [NASDAQ: MGX] stock has seen the most recent analyst activity on May 07, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, JP Morgan downgraded its rating to Neutral on May 02, 2024, and dropped its price target to $6. On March 05, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $25 on the stock. TD Cowen started tracking the stock assigning a Outperform rating. JP Morgan initiated its recommendation with a Overweight and recommended $16 as its price target on March 05, 2024. Jefferies started tracking with a Buy rating for this stock on March 05, 2024, and assigned it a price target of $23. In a note dated March 05, 2024, Chardan Capital Markets initiated an Buy rating and provided a target price of $21 on this stock.
Metagenomi Inc [MGX] stock has fluctuated between $1.23 and $4.92 over the past year. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Metagenomi Inc [NASDAQ: MGX] shares were valued at $2.69 at the most recent close of the market. An investor can expect a potential return of 439.03% based on the average MGX price forecast.
Analyzing the MGX fundamentals
Metagenomi Inc [NASDAQ:MGX] reported sales of 33.77M for the trailing twelve months, which represents a drop of -57.45%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -2.72%, Pretax Profit Margin comes in at -2.67%, and Net Profit Margin reading is -2.58%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.39 and Total Capital is -0.38. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.60 points at the first support level, and at 2.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.77, and for the 2nd resistance point, it is at 2.86.
Ratios To Look Out For
For context, Metagenomi Inc’s Current Ratio is 6.36. In addition, the Quick Ratio stands at 6.36 and the Cash Ratio stands at 0.81. Considering the valuation of this stock, the price to sales ratio is 2.99, the price to book ratio is 0.52.
Transactions by insiders
Recent insider trading involved Noonberg Sarah B., FORMER OFFICER, that happened on Sep 11 ’25 when 35832.0 shares were purchased. Affiliate, Sebastian Bernales completed a deal on Jul 09 ’25 to buy 0.77 million shares. Meanwhile, Wein Matthew sold 199.0 shares on Jun 06 ’25.
